Because conventional DNA polymerases synthesize DNA unidirectional wit
h a 5' to 3' polarity and require an RNA primer, telomeric DNA at chro
mosome ends is not completely replicated, leading to an end-replicatio
n problem. Most immortal eukaryotic cells can fully replicate chromoso
me ends by expressing the enzyme telomerase, a ribonucleoprotein that
uses an RNA template to add new telomeric repeats to the chromosome en
ds. Recently, the RNA components of human and mouse telomerases have b
een cloned, leading to new insights into the expression and regulation
of telomerase in both normal and cancer cells. Experiments with the h
uman telomerase RNA indicate the telomerase is essential for the long-
term growth of cancer cells. These findings further support our belief
that telomerase is an excellent target for a novel class of cancer th
erapeutics.